Skip to main content

Table 5 The overlap between CA125-positive samples (cut-off > 35 IU/mL) and the three DNAme marker panel (defined in Table 1) in cases and controls in the UKCTOCS “low DNA” nested case/control setting

From: The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer

 

Controls (CA125)

Cases (CA125)

Negative

Positive

Negative

Positive

3 DNAme marker panel

Negative

56

3

4

4

Positive

8

0

7

4